ConductScience.org, home

Gene · 2012

EMP1: epithelial membrane protein 1

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. EMP1: epithelial membrane protein 1. Genes, record 2012. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/2012

On this page

Gene

Symbol
EMP1
HGNC
Name
epithelial membrane protein 1
HGNC
NCBI Gene ID
2012
NCBI Gene
HGNC ID
HGNC:3333
HGNC
Ensembl
ENSG00000134531
NCBI Gene
Aliases
CL-20, EMP-1, TMP
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P54849Epithelial membrane protein 11570Ensembl, GeneID, HGNC

Source UniProt

Patents53

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1445124P54849Espacenet
EP 4650780 A22025-11-191611P54849Espacenet
EP 4641202 A22025-10-2963P54849Espacenet
JP 2025529142 A2025-09-041389P54849Espacenet
US 12371689 B22025-07-291389P54849Espacenet
JP 2025517970 A2025-06-121611P54849Espacenet
KR 1020250017231 A2025-02-0463P54849Espacenet
US 11446398 B22022-09-2027764P54849Espacenet
US 11400116 B22022-08-022368P54849Espacenet
JP 2022092366 A2022-06-22479P54849Espacenet

1 to 10 of 53

See all 53 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants841

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleEMP1 papersNewest fiscal year
P30ES013508Center of Excellence in Environmental Toxicology72025
R01ES029294Metabolic activation of nitroarenes and Nrf2-Keap162025
P30CA021765Cancer Center Support Grant (CCSG)52025
P51OD011132Emory National Primate Research Center52025
ZIALM200887Algorithmic approaches to systems biology, data integration, and evolution52025
P30CA076292Moffitt Cancer Center Support Grant42025
P01CA108671Myeloproliferative Neoplasms-Research Consortium32025
P30CA008748Cancer Center Support Grant32025
P30CA016520Abramson Cancer Center Support Grant32025
P30CA016672Cancer Center Support Grant32025

1 to 10 of 841Source NIH's project files

See all 841 nih grants

Papers1,540

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Substituent‑controlled energy‑sensitivity trade‑off in (E)-1,2-bis(tetrazolo[1,5-d][1,2,3,4]tetrazin-7(1H)-yl)diazene derivatives.J Mol Model202642776264PubTator, text miningPubMed
The Anisotropic Response and Initial Reaction Mechanism of a CL-20/MTNP High-Energy Cocrystal under Impact Loading.ACS Omega202642730066PubTator, text miningPubMed
Generalizable 3'-Hydroxyl-Regenerating Primer Platform for Photoactivatable DNA Polymerase Regulation in Nucleic Acid Amplification.Anal Chem202642689565PubTator, text miningPubMed
Physical Responses to the Structural Evolution of CL-20-Based Energetic Solvates with H2O2 and H2O Under External Electric Field.Int J Mol Sci202642653214PubTator, text miningPubMed
Pseudomorphic Replacement Driven Construction of Hierarchical Homostructured CL-20 Core-Shell Architectures for Safety Improvement.Small202642522771PubTator, text miningPubMed
Effect of Precompression on Detonation Performance and Products of Energetic Materials: Application to CL-20.J Phys Chem C Nanomater Interfaces202642416200PubTator, text miningPubMed
Correction: Expression analysis of epithelial membrane protein 1 (EMP1) gene in kidney stone patients.Int Urol Nephrol202642405990PubTator, text miningPubMed
Bridging local-global transmembrane protein contexts with contrastive pretraining for alignment-free pathogenicity prediction.Brief Bioinform202642398071PubTator, text miningPubMed
A Novel CAF-Related Signature for Precise Prediction of Clinical Outcomes and Immunotherapy Response for Breast Cancer Patients: Based on Multiomics Analyses and Experimental Validation.Mediators Inflamm202642359574PubTator, text miningPubMed
Preconditioning with sufentanil confers protective effects in transplantation by attenuating hepatic ischemia-reperfusion injury.World J Transplant202642281863PubTator, text miningPubMed

1 to 10 of 1,540

See all 1,540 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/2012

GET https://conductscience.org/api/genes/v1/2012/patents?page=2